PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Science Valley Research Institute, São Paulo, Brazil; Hospital e Maternidade Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil. Electronic address: ramacciotti@svriglobal.com.\', \'Science Valley Research Institute, São Paulo, Brazil.\', \'Unidade de Medicina Interdisciplinar em Cardiologia, Instituto do Coração, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.\', \'Science Valley Research Institute, São Paulo, Brazil; Hospital e Maternidade Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil.\', \'Zucker School of Medicine at Hofstra/Northwell and the Feinstein Institutes for Medical Research, Manhasset, NY, USA; Department of Obstetrics and Gynecology, I M Sechenov First Moscow State Medical University, Moscow, Russia.\', \'Hospital e Maternidade Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil.\', \'Universidade Estadual Paulista, Botucatu, Brazil.\', \'Hospital das Clínicas de Ribeirão Preto, São Paulo University Medical School, Ribeirão Preto, São Paulo, Brazil.\', \'Hospital do Rocio, Campo Largo, Paraná, Brazil.\', \'Instituto Couto Maia, Salvador, Bahia, Brazil.\', \'Hospital Municipal de Barueri, São Paulo, Brazil.\', \'São Paulo State Public Women\'s Health Reference Center, São Paulo, Brazil.\', \'Hospital Israelita Albert Einstein, São Paulo, Brazil.\', \'Instituto do Coração, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.\', \'Institute of Teaching and Research Hapvida, Fortaleza, CE, Brazil.\', \'Hospital Nossa Senhora das Graças, Curitiba, Brazil.\', \'Department of Statistics, Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil.\', \'Northshore University Health System, Chicago, IL, USA.\', \'Hemostasis and Thrombosis Research Laboratories at Loyola University Medical Center, Maywood, IL, USA.\', \'Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0140-6736(21)02392-810.1016/S0140-6736(21)02392-8
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34921756
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34921756>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34921756>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all